Toragen is focused on repurposing anti-viral drugs and developing novel immunotherapies to treat viral-associated cancers.

Biotechnology

Toragen, Inc.

Sandra Coufal

Richard Lumpkin

Neil Clendeninn

Anita Busquets

Andrew Sharabi

Dennis Carson

Penelope Duerksen-Hughes

Paul Engler

Aldo Venuti

John Major

Kimberly Manhard

William Degrado

Ezra Cohen

This department oversees strategic direction and decision-making for the organization.

Leadership

The Scientific Team at Toragen, Inc. is responsible for conducting research on repurposing antiviral drugs and developing innovative immunotherapies aimed at treating viral-associated cancers. This team of Scientific Advisors collaborates on designing experiments, analyzing data, and translating scientific discoveries into effective therapeutic solutions.

Scientific Team

The Leadership Team at Toragen, Inc. comprises the CEO, CFO, CMO, and CSO, who collectively drive the company's strategic vision. They oversee operations, financial planning, clinical development, and scientific research to advance the repurposing of antiviral drugs and the creation of novel immunotherapies for treating viral-associated cancers.

Leadership Team

This department focuses on advancing scientific knowledge and developing new products through research and experimentation.

Toragen, Inc.

Org chart

Board & advisors

Teams

Leadership

Scientific Team

Leadership Team

Research and Development

Offices

Toragen, Inc.

Org chart

Board & advisors

Teams

Leadership

Scientific Team

Leadership Team

Research and Development

Offices

Related companies